Literature DB >> 20119937

Psychological distress in patients with pancreatic cancer--an understudied group.

Karen L Clark1, Matthew Loscalzo, Peter C Trask, James Zabora, Errol J Philip.   

Abstract

BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer-related death in the United States, unsuccessful in significantly improving 5-year survival. A diagnosis of pancreatic cancer may be associated with increased psychological distress, yet remarkably little is known about the degree of psychological distress experienced by these patients at the time of diagnosis and treatment.
METHOD: In a cross-sectional study, 304 patients with pancreatic cancer and 7749 patients with other cancer diagnoses completed the Brief Symptom Inventory (BSI) or the Brief Symptom Inventory-Shortened Version (BSI-18) and the Problem Common Checklist (PCL) during outpatient registration. Sociodemographic characteristics were collected from patients' clinical files.
RESULTS: A higher percentage of pancreatic cancer patients reported elevated distress across each subscale of the BSI and BSI-18 when compared with those diagnosed with other cancer diagnoses as a group. The most notable difference was established on the depression subscale, with 28.8% of pancreatic patients reporting elevated depression compared with 18.5% of other cancer diagnoses. In pancreatic patients, a significant difference was also found in the percentage of males endorsing high depression levels when compared with females (34.0 vs 22.6%, p<0.05).
CONCLUSIONS: Pancreatic cancer patients demonstrate elevated levels of psychological distress. This should alert providers to be vigilant in evaluating patients for distress and to provide appropriate referrals. The endorsement of fatigue and pain, along with the observed gender differences, suggest that early distress management interventions may need to include components targeted to these issues.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20119937     DOI: 10.1002/pon.1697

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  30 in total

1.  Using photography to explore psychological distress in patients with pancreatic cancer and their caregivers: a qualitative study.

Authors:  Shan S Wong; Thomas J George; Melyssa Godfrey; Jennifer Le; Deidre B Pereira
Journal:  Support Care Cancer       Date:  2018-06-29       Impact factor: 3.603

2.  Perspectives of newly diagnosed advanced cancer patients receiving dignity therapy during cancer treatment.

Authors:  Ann Marie Dose; Lori M Rhudy
Journal:  Support Care Cancer       Date:  2017-07-21       Impact factor: 3.603

Review 3.  Palliative care and advance care planning for pancreas and other cancers.

Authors:  Rajiv Agarwal; Andrew S Epstein
Journal:  Chin Clin Oncol       Date:  2017-06

4.  Pilot study of an interdisciplinary supportive care planning intervention in pancreatic cancer.

Authors:  Virginia Sun; Nora Ruel; Vincent Chung; Gagandeep Singh; Lucille Leong; Marwan Fakih; Yuman Fong; Betty Ferrell
Journal:  Support Care Cancer       Date:  2016-03-17       Impact factor: 3.603

5.  The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma.

Authors:  Casey A Boyd; Jaime Benarroch-Gampel; Kristin M Sheffield; Yimei Han; Yong-Fang Kuo; Taylor S Riall
Journal:  Surgery       Date:  2012-09       Impact factor: 3.982

6.  Biobehavioral approaches to cancer progression and survival: Mechanisms and interventions.

Authors:  Susan K Lutgendorf; Barbara L Andersen
Journal:  Am Psychol       Date:  2015 Feb-Mar

7.  Pancreatic cancer and depression: myth and truth.

Authors:  Martina Mayr; Roland M Schmid
Journal:  BMC Cancer       Date:  2010-10-20       Impact factor: 4.430

8.  Pancreatic cancer and supportive care--pancreatic exocrine insufficiency negatively impacts on quality of life.

Authors:  H M Gooden; K J White
Journal:  Support Care Cancer       Date:  2013-02-10       Impact factor: 3.603

9.  Determining desire to live among patients with advanced hepatobiliary-pancreatic cancer for whom curative treatment is not indicated.

Authors:  Junko Morishita; Tomoko Inoue
Journal:  Glob Health Med       Date:  2021-06-30

10.  β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer.

Authors:  Bernhard W Renz; Ryota Takahashi; Takayuki Tanaka; Marina Macchini; Yoku Hayakawa; Zahra Dantes; H Carlo Maurer; Xiaowei Chen; Zhengyu Jiang; C Benedikt Westphalen; Matthias Ilmer; Giovanni Valenti; Sarajo K Mohanta; Andreas J R Habenicht; Moritz Middelhoff; Timothy Chu; Karan Nagar; Yagnesh Tailor; Riccardo Casadei; Mariacristina Di Marco; Axel Kleespies; Richard A Friedman; Helen Remotti; Maximilian Reichert; Daniel L Worthley; Jens Neumann; Jens Werner; Alina C Iuga; Kenneth P Olive; Timothy C Wang
Journal:  Cancer Cell       Date:  2017-12-14       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.